AC
CBPO

Athanor Capital’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Athanor Capital’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,604
Closed -$308K – 1036
2021
Q1 		$308K Sell
2,604
-3,561
-58% -$421K 0.01% 589
2020
Q4 		$728K Sell
6,165
-10,815
-64% -$1.26M 0.02% 387
2020
Q3 		$1.89M Buy
16,980
+7,696
+83% +$826K 0.07% 148
2020
Q2 		$949K Buy
+9,284
New +$993K 0.05% 198

Athanor Capital's CBPO Position: Q2 2021 in Review

Athanor Capital sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 2,604 shares — an estimated $308K sold.

Athanor Capital first reported a position in CBPO in Q2 2020 and held it in 4 quarters. The position peaked at $1.89M in Q3 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • Athanor Capital reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
  • Athanor Capital sold 2,604 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $308K.
  • Athanor Capital first reported a position in China Biologic Products Holdings, Inc. in Q2 2020 and held it in 4 quarters.
  • Athanor Capital's China Biologic Products Holdings, Inc. position peaked at $1.89M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.